In order to provide the most biologically active proteins, many of Leinco Technologies’ proteins are expressed using mammalian host cells,
Recombinant Proteins including Growth Factors & Cytokines
Diaclone Recombinant proteins: Human SARS-COV-2 and cytokines for immune response studies
Diaclone have developed a series of high-quality recombinant proteins, for research into Human SARS-CoV-2 and immune responses. Diaclone’s proteins are suitable for a wide range of applications, including cell culture, immunoassays, bioassays and more. These proteins are now available in
Interleukin-6 release in response to Coronavirus 19
Coronavirus 19 is known to infect the respiratory tract and cause mild or highly acute respiratory syndrome. A consequence of this is the release of pro-inflammatory cytokines, including interleukin (IL)-1β and IL-6 (1). This hyperinflammatory response is thought to be
The Dark Side of CAR-T Therapy – Cytokine Release Syndrome (Diaclone)
Immunotherapies such as monoclonal antibodies, bispecific antibodies (Bi-specific T-cell engagers or BiTEs) and adoptive T-cell therapies (e.g. CAR-modified T-cell) have provided great advances in cancer treatment. However, testing new therapies is not without risk. The most common and potentially severe